Emcure Pharmaceuticals Announces 45th AGM for FY25-26

Emcure Pharmaceuticals Limited has announced its Annual Report for the Financial Year 2025-26, along with the Notice of its 45th Annual General Meeting (AGM). The AGM is scheduled for Monday, September 21, 2026, at 11:00 a.m. IST, to be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). Members holding shares as of Monday, September 14, 2026, are eligible to attend and participate in remote e-voting, which will be open from Friday, September 18, 2026, 9:00 a.m. IST, to Sunday, September 20, 2026, 5:00 p.m. IST. The report highlights key financial and operational achievements, including revenue from operations of INR 92,035 Mn, ROCE of 23.7%, and an EBITDA margin of 19.4%. The company operates in over 80 countries and holds the #2 rank in Gynaecology in India.